Inventor · disambiguated record
Lori Jean Patterson
Also filed as: PATTERSON LORI JEAN
32 granted patents·5 pending applications·272 citations·filing 2009–2024
98Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC12STANGELAND ERIC L11PATTERSON LORI JEAN7THERAVANCE INC4STANGELAND ERIC3
Top patents by PatentIndex Score
37 records- 0197US10946006B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Mar 16, 2021·4 cites·25 claims
- 0297US10722504B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jul 28, 2020·5 cites·18 claims
- 0397US10206913B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 19, 2019·11 cites·2 claims
- 0497US10034870B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 31, 2018·12 cites·10 claims
- 0597US9675599B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2015·Granted Jun 13, 2017·17 cites·4 claims
- 0696US9073859B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compoundPATTERSON LORI JEAN·Filed 2013·Granted Jul 7, 2015·18 cites·7 claims
- 0796US8604058B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2012·Granted Dec 10, 2013·20 cites·24 claims
- 0896US8304432B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2009·Granted Nov 6, 2012·25 cites·26 claims
- 0996US8304433B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundPATTERSON LORI JEAN·Filed 2009·Granted Nov 6, 2012·23 cites·9 claims
- 1095US10946007B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Mar 16, 2021·2 cites·4 claims
- 1195US10441579B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Oct 15, 2019·7 cites·9 claims
- 1295US10226454B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Mar 12, 2019·8 cites·18 claims
- 1395US9162982B24-[2-(2-fluorophenoxy methyl)phenyl]piperidine compoundsPATTERSON LORI JEAN·Filed 2013·Granted Oct 20, 2015·15 cites·20 claims
- 1495US8592596B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE INC·Filed 2012·Granted Nov 26, 2013·15 cites·5 claims
- 1595US7888386B23-(phenoxyphenylmethyl)pyrrolidine compoundsTHERAVANCE INC·Filed 2009·Granted Feb 15, 2011·30 cites·54 claims
- 1694US10576073B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 3, 2020·6 cites·11 claims
- 1791US11596624B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Mar 7, 2023·1 cites·7 claims
- 1890US7994209B23-phenoxymethylpyrrolidine compoundsTHERAVANCE INC·Filed 2010·Granted Aug 9, 2011·14 cites·4 claims
- 1989US12239638B2Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Mar 4, 2025·0 cites·14 claims
- 2088US8242164B23-(phenoxyphenylmethyl)pyrrolidine compoundsSTANGELAND ERIC L·Filed 2011·Granted Aug 14, 2012·9 cites·9 claims
- 2188US2024316024A14-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2024·Application pending·0 cites
- 2286US9012460B21-(2-phenoxymethylphenyl)piperazine compoundsSTANGELAND ERIC L·Filed 2014·Granted Apr 21, 2015·7 cites·3 claims
- 2386US8530663B21-(2-phenoxymethylheteroaryl)piperidine and piperazine compoundsSTANGELAND ERIC L·Filed 2011·Granted Sep 10, 2013·8 cites·13 claims
- 2485US8778949B21-(2-phenoxymethylphenyl)piperazine compoundsSTANGELAND ERIC L·Filed 2011·Granted Jul 15, 2014·7 cites·8 claims
- 2580US11723900B24-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 15, 2023·0 cites·5 claims
- 2679US8471040B2Serotonin reuptake inhibitorsSTANGELAND ERIC L·Filed 2011·Granted Jun 25, 2013·3 cites·21 claims
- 2776US8273786B23-phenoxymethylpyrrolidine compoundsSTANGELAND ERIC·Filed 2010·Granted Sep 25, 2012·3 cites·24 claims
- 2874US8455665B23-phenoxymethylpyrrolidine compoundsSTANGELAND ERIC·Filed 2012·Granted Jun 4, 2013·2 cites·16 claims
- 2964US2016022660A1Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compoundPATTERSON LORI JEAN·Filed 2015·Application pending·0 cites
- 3063US9000191B2Serotonin reuptake inhibitorsSTANGELAND ERIC L·Filed 2013·Granted Apr 7, 2015·0 cites·2 claims
- 3160US8729119B2Serotonin reuptake inhibitorsSTANGELAND ERIC L·Filed 2013·Granted May 20, 2014·0 cites·18 claims
- 3259US8853255B23-phenoxymethylpyrrolidine compoundsSTANGELAND ERIC L·Filed 2013·Granted Oct 7, 2014·0 cites·10 claims
- 3357US8933249B23-(phenoxyphenylmethyl)pyrrolidine compoundsSTANGELAND ERIC L·Filed 2012·Granted Jan 13, 2015·0 cites·28 claims
- 3451US2013324550A11-(2-phenoxymethylheteroaryl) piperidine and piperazine compoundsSTANGELAND ERIC L·Filed 2013·Application pending·0 cites
- 3551US2011257243A13-phenoxymethylpyrrolidine compoundsTHERAVANCE INC·Filed 2011·Application pending·0 cites
- 3650US9227933B23-phenoxymethylpyrrolidine compoundsSTANGELAND ERIC·Filed 2015·Granted Jan 5, 2016·0 cites·24 claims
- 3735US2010267743A13-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compoundsSTANGELAND ERIC L·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →